Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...
Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 ...
Soon if you visit a medical specialist, you may notice a fact sheet plastered on the wall. It will encourage you to ask questions, and outline five simple things to consider when speaking to your ...
On the eve of New Scientist’s 70th anniversary, newsroom legend Andy Coghlan reveals four of the most dramatic and surprising ...
Washington State University researchers have engineered a targeted nanotherapy that could yield a medical breakthrough to ...
Becton, Dickinson and Company (NYSE:BDX) has steady demand for its medical devices, together with a long history of paying ...
Chung spent over two decades caring for combat casualties and is scheduled to give the Oct. 15 keynote on kidney injury in ...
7d
People say these peptides hurt them. Their stories are muffled in MAHA’s push for medical freedom
Companies are required to warn that experimental peptides, which haven’t been approved by the FDA, are for research use only.
Anmol Saini’s medical research is helping to give hope to South Australian women who are struggling to become pregnant.
(9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study ...
From cutting heart valves without open-heart surgery to confronting Israel’s growing medical brain drain, Sheba cardiologist ...
NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results